Related Experiment Video
Updated: Jan 26, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Body mass index trajectories in pediatric multiple sclerosis
J Nicholas Brenton1, Emma Woolbright2, Christina Briscoe-Abath3
1Pediatric Neurology, Department of Neurology, University of Virginia, Charlottesville, VA, USA.
Insights
Children with multiple sclerosis show higher body mass index (BMI) z-scores years before diagnosis. This indicates increased overweight prevalence in pediatric multiple sclerosis patients from early childhood.
Area of Science:
- Pediatric Neurology
- Growth and Development
- Chronic Disease Epidemiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with a significant impact on pediatric populations.
- Understanding growth patterns in children with MS is crucial for early identification and management.
- Previous research has not fully characterized the growth trajectories of children who develop MS.
Purpose of the Study:
- To compare the growth trajectories of children who develop multiple sclerosis (MS) with those of typically developing peers.
- To assess body mass index (BMI) z-scores in pediatric MS cases relative to matched controls and Centers for Disease Control (CDC) normative data.
- To investigate BMI differences in relation to the age of MS onset.
Main Methods:
- A case-control study involving 40 pediatric MS patients and 120 typically developing controls, matched for age, sex, ethnicity, and socioeconomic status.
- Collection of weight, height, and BMI data for all participants.
- Conversion of BMI values to z-scores using CDC reference data for comparison across cohorts and in relation to MS onset.
Main Results:
- Pediatric MS patients exhibited significantly higher BMI z-scores compared to both typically developing peers and CDC normative values.
- These significant BMI differences were observed starting from 4 years of age, predating clinical MS onset (median onset age 15 years).
- Height trajectories were comparable between the MS cohort, control group, and CDC standards.
Conclusions:
- Body mass index is markedly elevated in children with MS, beginning in early childhood, years prior to clinical disease manifestation.
- Pediatric MS patients are significantly more overweight at diagnosis than their typically developing counterparts.
- Elevated BMI trajectories may serve as an early indicator or risk factor in the development of pediatric multiple sclerosis.
Aim:
To characterize growth trajectories of children who develop multiple sclerosis compared to typically developing, regional peers and Centers for Disease Control (CDC) normative values.
Method:
This case-control study collected weight, height, and body mass index (BMI) in 40 consecutive pediatric patients with multiple sclerosis (28 females, 12 males), in addition to 120 typically developing peers (84 females, 36 males), identified and matched for year of birth, sex, ethnicity, and socio-economic status. BMI values were converted to z-scores based on CDC reference values and were compared with respect to age between our two cohorts and by years relative to multiple sclerosis onset for cases.
Results:
Median age for the clinical onset of multiple sclerosis was 15 years. BMI z-scores are significantly higher for patients with multiple sclerosis compared to typically developing, demographically-matched peers and CDC standards. These significant differences in BMI are noted from 4 years of age and onward. Height trajectories were similar among case and control individuals and CDC normative values.
Interpretation:
BMI in pediatric multiple sclerosis is markedly higher, beginning in early childhood, years before the clinical-onset of the disease.
What This Paper Adds:
Children with multiple sclerosis are significantly more overweight than typically developing peers at the time of diagnosis. Body mass index trajectories are significantly higher years before the clinical manifestation(s) of multiple sclerosis.
Related Concept Videos
Reduced Mass Coordinates: Isolated Two-body Problem
Multiple Allele Traits
Atomic Mass
Molar Mass
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution

